HARRELL INVESTMENT PARTNERS, LLC

Position in LLY — ELI LILLY & Co

CIK 1802882 AUSTIN, TX

Position in LLY

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$700,467

+$77,783 QoQ

Shares Held

584

-13.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

#3,450

of 4,604 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

HARRELL INVESTMENT PARTNERS, LLC holds $21,101,607 across 6 Drug Manufacturers - General names. LLY ranks #5 (3.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	40,541	$10,296,197
2	ABBV	AbbVie Inc.	31,506	$7,928,169
3	NVS	Novartis AG	6,498	$1,018,366
4	NVO	Novo Nordisk A S	16,042	$769,053
5	LLY	ELI LILLY & Co This page	584	$700,467
6	MRK	Merck & Co., Inc.	3,030	$389,355

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$700,467	584	-13.7%	Shares	Sole	2026-07-09
2026-03-31	$622,684	677	+3.8%	Shares	Sole	2026-04-22
2025-12-31	$700,691	652	+11.1%	Shares	Sole	2026-01-15
2025-09-30	$447,881	587	-0.3%	Shares	Sole	2025-10-23
2025-06-30	$459,143	589	-18.0%	Shares	Sole	2025-07-15
2025-03-31	$593,003	718	+34.5%	Shares	Sole	2025-04-21
2024-12-31	$412,248	534	+12.7%	Shares	Sole	2025-01-21
2024-09-30	$419,935	474	-0.6%	Shares	Sole	2024-10-11
2024-06-30	$431,866	477	+3.5%	Shares	Sole	2024-07-18
2024-03-31	$358,639	461	+1.5%	Shares	Sole	2024-05-10
2023-12-31	$264,645	454	0.0%	Shares	Sole	2024-01-22
2023-09-30	$243,857	454	+0.2%	Shares	Sole	2023-10-30
2023-06-30	$212,447	453	—	Shares	Sole	2023-08-08
No filing history on record for this holder in this stock.